1. Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions

   • Ettore Beghi
   • Giorgia Giussani
   • Andrea Sylvia Winkler

   Review 21 October 2021 Pages: 2265 - 2274

2. Determinants of COVID-19-related lethality in multiple sclerosis: a meta-regression of observational studies

   • Luca Prosperini
   • Carla Tortorella
   • Claudio Gasperini

   Original Communication 04 January 2022 Pages: 2275 - 2285

   

3. Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod

   • Anat Achiron
   • Mathilda Mandel
   • Rina Falb

   Original Communication 02 March 2022 Pages: 2286 - 2292

   

4. Encephalopathy as a prognostic factor in adults with acute disseminated encephalomyelitis following COVID-19

   • Stefano Gelibter
   • Gabriele Bellavia
   • Carlo Dallocchio

   Short Commentary 03 January 2022 Pages: 2293 - 2300

   

5. A comparative safety study of reported neurological adverse events with three COVID-19 vaccines

   • Mohit Sodhi
   • Ali Samii
   • Mahyar Etminan

   Letter to the Editors 09 January 2022 Pages: 2301 - 2303

6. Neuroinflammation in Parkinson's disease: a meta-analysis of PET imaging studies

   • Peng-Fei Zhang
   • Fan Gao

   Review 01 November 2021 Pages: 2304 - 2314

   

7. Pharmacological and non-pharmacological management of spinocerebellar ataxia: A systematic review

   • Kah Hui Yap
   • Shahrul Azmin
   • Norlinah Mohamed Ibrahim

   Review 06 November 2021 Pages: 2315 - 2337

   

8. The efficacy and safety of insertable cardiac monitor on atrial fibrillation detection in patients with ischemic stroke: a systematic review and meta-analysis

   • Xin Tan
   • Zilan Wang
   • Gang Chen

   Review 20 November 2021 Pages: 2338 - 2345

   

9. Myocardial infarction, stroke and cardiovascular mortality among migraine patients: a systematic review and meta-analysis

   • Chester Yan Hao Ng
   • Benjamin Y. Q. Tan
   • Jonathan J. Y. Ong

   Review 08 January 2022 Pages: 2346 - 2358

   

10. A perspective on persistent toxicants in veterans and amyotrophic lateral sclerosis: identifying exposures determining higher ALS risk

    • Diane B. Re
    • Beizhan Yan
    • Elijah W. Stommel

    Review Open access 01 January 2022 Pages: 2359 - 2377

11. Neural correlates of dual-task walking in people with central neurological disorders: a systematic review

    • Hyejun Kim
    • Sarah Fraser

    Review 06 January 2022 Pages: 2378 - 2402

    

12. Innovative therapeutic concepts of progressive multifocal leukoencephalopathy

    • Nora Möhn
    • Lea Grote-Levi
    • Thomas Skripuletz

    Review Open access 07 January 2022 Pages: 2403 - 2413

    

13. Diagnostic interest of whole-body MRI in early- and late-onset LAMA2 muscular dystrophies: a large international cohort

    • Susana Quijano-Roy
    • Jana Haberlova
    • Robert Y. Carlier

    Original Communication 24 September 2021 Pages: 2414 - 2429

    

14. Narcolepsy genetic marker HLA DQB1*06:02 and excessive daytime sleepiness in Parkinson disease patients treated with dopaminergic agents

    • Octavian Adam
    • Sharmeen Azher
    • Eric Molho

    Original Communication 24 September 2021 Pages: 2430 - 2439

    

15. Pathological neural networks and artificial neural networks in ALS: diagnostic classification based on pathognomonic neuroimaging features

    • Peter Bede
    • Aizuri Murad
    • Orla Hardiman

    Original Communication Open access 28 September 2021 Pages: 2440 - 2452

    

16. Self-injurious behavior in Tourette syndrome

    • José Fidel Baizabal-Carvallo
    • Marlene Alonso-Juarez
    • Joseph Jankovic

    Original Communication 01 October 2021 Pages: 2453 - 2459

    

17. Sleep-disordered breathing-related symptoms and risk of stroke: cohort study and Mendelian randomization analysis

    • Olga E. Titova
    • Shuai Yuan
    • Susanna C. Larsson

    Original Communication Open access 01 October 2021 Pages: 2460 - 2468

    

18. Associations of sleep disorders with cerebrospinal fluid α-synuclein in prodromal and early Parkinson’s disease

    • Xiao-Tong Wang
    • Huan Yu
    • Jin-Tai Yu

    Original Communication 04 October 2021 Pages: 2469 - 2478

    

19. Estimating the X chromosome-mediated risk for developing Alzheimer’s disease

    • Carmel Armon
    • Sharon Wolfson
    • Ran Shorer

    Original Communication 05 October 2021 Pages: 2479 - 2485

20. Characteristics of clinical relapses and patient-oriented long-term outcomes of patients with anti-N-methyl-d-aspartate receptor encephalitis

    • Satoshi Hirose
    • Makoto Hara
    • Hideto Nakajima

    Original Communication 06 October 2021 Pages: 2486 - 2492

    

21. Safety and outcomes of endovascular treatment in patients with very severe acute ischemic stroke

    • Fouzi Bala
    • Nicolas Bricout
    • Barbara Casolla

    Original Communication 07 October 2021 Pages: 2493 - 2502

    

22. Brain network topology and future development of freezing of gait in Parkinson’s disease: a longitudinal study

    • Nannan Li
    • Du Lei
    • Rong Peng

    Original Communication 07 October 2021 Pages: 2503 - 2512

    

23. Real-world application of autologous hematopoietic stem cell transplantation in 507 patients with multiple sclerosis

    • Richard K. Burt
    • Xiaoqiang Han
    • Roumen Balabanov

    Original Communication 11 October 2021 Pages: 2513 - 2526

    

24. In vivo assessment of OXPHOS capacity using 3 T CrCEST MRI in Friedreich’s ataxia

    • Gayatri Maria Schur
    • Julia Dunn
    • Shana E. McCormack

    Original Communication Open access 15 October 2021 Pages: 2527 - 2538

    

25. Quantitative clinical and radiological recovery in post-operative patients with superficial siderosis by an iron chelator

    • Yurie Nose
    • Ikuko Uwano
    • Nobuo Sanjo

    Original Communication 18 October 2021 Pages: 2539 - 2548

    

26. Opinion, knowledge, and clinical experience with functional neurological disorders among Italian neurologists: results from an online survey

    • Michele Tinazzi
    • Mirta Fiorio
    • Angela Marotta

    Original Communication Open access 19 October 2021 Pages: 2549 - 2559

    

27. Quality of life in individuals newly diagnosed with multiple sclerosis or clinically isolated syndrome

    • Kevin N. Alschuler
    • Daniel Whibley
    • Dawn M. Ehde

    Original Communication 19 October 2021 Pages: 2560 - 2572

    

28. Baseline MRI atrophy predicts 2-year cognitive outcomes in early-onset Alzheimer’s disease

    • José Contador
    • Agnès Pérez-Millan
    • Albert Lladó

    Original Communication 19 October 2021 Pages: 2573 - 2583

    

29. Diagnostic accuracy and usability of the EMBalance decision support system for vestibular disorders in primary care: proof of concept randomised controlled study results

    • Doris-Eva Bamiou
    • Dimitris Kikidis
    • Linda M. Luxon

    Original Communication Open access 20 October 2021 Pages: 2584 - 2598

    

30. Interval timing and midfrontal delta oscillations are impaired in Parkinson’s disease patients with freezing of gait

    • Taylor J. Bosch
    • Richa Barsainya
    • Arun Singh

    Original Communication 21 October 2021 Pages: 2599 - 2609

    

31. Energy expenditure, body composition and dietary habits in progressive supranuclear palsy

    • Marina Picillo
    • Maria Francesca Tepedino
    • Paolo Barone

    Original Communication 21 October 2021 Pages: 2610 - 2618

    

32. Involvement of cortico-efferent tracts in flail arm syndrome: a tract-of-interest-based DTI study

    • Angela Rosenbohm
    • Kelly Del Tredici
    • Jan Kassubek

    Original Communication Open access 21 October 2021 Pages: 2619 - 2626

    

33. The persistence of seizures after tumor resection negatively affects survival in low-grade glioma patients: a clinical retrospective study

    • Edoardo Mazzucchi
    • Catello Vollono
    • Tamara Ius

    Original Communication 25 October 2021 Pages: 2627 - 2633

    

34. Influence of a clinical trial in the decision-making processes of patients with amyotrophic lateral sclerosis

    • Chris Kato
    • Satoru Morimoto
    • Daisuke Ito

    Original Communication 25 October 2021 Pages: 2634 - 2640

    

35. Prognosis value of serum soluble ST2 level in acute ischemic stroke and STEMI patients in the era of mechanical reperfusion therapy

    • Laura Mechtouff
    • Alexandre Paccalet
    • Thomas Bochaton

    Original Communication 25 October 2021 Pages: 2641 - 2648

    

36. GABRB3-related epilepsy: novel variants, clinical features and therapeutic implications

    • Ying Yang
    • Qi Zeng
    • Yuehua Zhang

    Original Communication 26 October 2021 Pages: 2649 - 2665

    

37. Nationwide incidence of myotonic dystrophy type 1 and the status of multi-organ involvement

    • Ju-Yeun Lee
    • Ha-Neul Jeong

    Original Communication 26 October 2021 Pages: 2666 - 2672

    

38. Feasibility of a continuous, multi-sensor remote health monitoring approach in persons living with neurodegenerative disease

    • F. Elizabeth Godkin
    • Erin Turner
    • Karen Van Ooteghem

    Original Communication 27 October 2021 Pages: 2673 - 2686

    

39. Vestibular impairments in episodic ataxia type 2

    • Jae-Hwan Choi
    • Eun Hye Oh
    • Kwang-Dong Choi

    Original Communication 28 October 2021 Pages: 2687 - 2695

    

40. Functional network dynamics and decreased conscientiousness in multiple sclerosis

    • Tom A. Fuchs
    • Menno M. Schoonheim
    • Ralph H. B. Benedict

    Original Communication 29 October 2021 Pages: 2696 - 2706

    

41. Acute symptomatic seizures in the emergency room: predictors and characteristics

    • Lili C. S. Reinecke
    • Jakob I. Doerrfuss
    • Martin Holtkamp

    Original Communication Open access 02 November 2021 Pages: 2707 - 2714

    

42. Increased aneurysm wall permeability colocalized with low wall shear stress in unruptured saccular intracranial aneurysm

    • Yajie Wang
    • Jie Sun
    • Huijun Chen

    Original Communication 03 November 2021 Pages: 2715 - 2719

    

43. Nitrous oxide-induced predominantly motor neuropathies: a follow-up study

    • Edouard Berling
    • Guillaume Fargeot
    • Adrien Zanin

    Original Communication 06 November 2021 Pages: 2720 - 2726

    

44. Clinical characteristics and outcome of hydrocephalus in neurosarcoidosis: a retrospective cohort study and review of the literature

    • Leroy ten Dam
    • Diederik van de Beek
    • Matthijs C. Brouwer

    Original Communication Open access 07 November 2021 Pages: 2727 - 2733

    

45. Inter-method reliability of the modified Rankin Scale in patients with subarachnoid hemorrhage

    • E. Nobels-Janssen
    • E. N. Postma
    • H. D. Boogaarts

    Original Communication Open access 08 November 2021 Pages: 2734 - 2742

    

46. Can intracranial time-of-flight-MR angiography predict extracranial carotid artery stenosis?

    • Filiz Osmanodja
    • Jan F. Scheitz
    • Kersten Villringer

    Original Communication Open access 09 November 2021 Pages: 2743 - 2749

    

47. Epilepsy related multimorbidity, polypharmacy and risks in adults with intellectual disabilities: a national study

    • James J. Sun
    • Bhathika Perera
    • Rohit Shankar

    Original Communication 24 January 2022 Pages: 2750 - 2760

48. Correction to: Epilepsy related multimorbidity, polypharmacy and risks in adults with intellectual disabilities: a national study

    • James J. Sun
    • Bhathika Perera
    • Rohit Shankar

    Correction 05 March 2022 Pages: 2761 - 2761

49. Olfactory impairment in autoimmune encephalitis: another piece of the puzzle

    • Alessandra Morano
    • Emanuele Cerulli Irelli
    • Carlo Di Bonaventura

    Short Commentary 10 January 2022 Pages: 2762 - 2768

    

50. Efficacy of nilotinib in monozygotic twins with spinocerebellar ataxia type 6

    • Seo-Young Choi
    • Hyo-Jung Kim
    • Ji-Soo Kim

    Letter to the Editors 17 November 2021 Pages: 2769 - 2773